Analyst Ratings for Axsome Therapeutics Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter: Benzinga · Jun 29, 2022
Where Axsome Therapeutics Stands With Analysts Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter: Benzinga · May 3, 2022
A Preview Of Axsome Therapeutics's Earnings Axsome Therapeutics (NASDAQ:AXSM) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Axsome Therapeutics will report an earnings per share (EPS) of $-1.00. Benzinga · Apr 29, 2022
Axsome Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know Axsome Therapeutics (NASDAQ:AXSM) will host a conference call at 08:00 AM ET on May 2, 2022, to discuss Q1 2022 earnings results. Benzinga · Apr 26, 2022
Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment. Benzinga · Feb 2, 2022